AI assistant
PFIZER INC — Director's Dealing 2008
Mar 4, 2008
29831_dirs_2008-03-03_5fb69a10-7bcb-4652-be25-436068b04f9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2008-02-28
Reporting Person: KINDLER JEFFREY B (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-28 | Common Stock | A | 98771 | — | Acquired | 314596.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-29 | Phantom Stock Units SSP | $ | A | 40 | Acquired | Common Stock (40.00) | Direct | |
| 2008-02-28 | Stock Appreciation Rights | $22.55 | A | 399645 | Acquired | 2013-02-28 | Common Stock (399645.00) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3256.00 | Indirect |
| Common Stock | 650.00 | Indirect |
| Common Stock | 650.00 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units.
F2: Each unit represents one phantom share of common stock.
F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
F4: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant